Psyched Wellness Initiates Study on AME-1 Extract for Gut Health Post published:March 30, 2021 Post category:Press Release
Psyched Wellness Provides Update on Pre-Clinical Trial of Its Muscimol Extract AME-1 Post published:March 2, 2021 Post category:Press Release
Psyched Wellness Closes $6,603,000 Bought Deal Private Placement Post published:February 17, 2021 Post category:Press Release
Psyched Wellness Provides Update on Antioxidant and Anti-Inflammatory Study of Muscimol Post published:February 4, 2021 Post category:Press Release
Psyched Wellness Upsizes Previously Announced Bought Deal Offering Post published:January 25, 2021 Post category:Press Release
Psyched Wellness Announces C$3M Bought Deal Private Placement Led by Canaccord Genuity Post published:January 21, 2021 Post category:Press Release
Psyched Wellness Announces New OTCQB Ticker: PSYCF Post published:January 19, 2021 Post category:Press Release
Psyched Wellness Completes Initial Data Review to Determine Clinical Path for Muscimol Post published:January 14, 2021 Post category:Press Release
Psyched Wellness Commences Antioxidant and Anti-Inflammatory Study on Muscimol Post published:January 6, 2021 Post category:Press Release
Psyched Wellness Has Commenced Research on Muscimol for Various Ailments Post published:December 28, 2020 Post category:Press Release